Back

Validation of a variable loop circular pulsed field ablation catheter for assessment of pulmonary vein isolation by 3D mapping

30 March 2025 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session 1: atrial tachyarrhythmias Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Thomas Kueffer

Bern University Hospital, Inselspital, Bern (Switzerland)

156 More presentations in this session

Presentation thumbnail
Native left atrial tachycardias clinical and electrophysiological characteristics: insights from a national survey.
Doctor S. Bun (Nice, FR)
Abstract
Presentation thumbnail
A novel immersive catheter ablation simulator based on individualized 3D MR patients' heart models improves ablation performance of future electrophysiologists.
Ms N. Bacha (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Safety and feasibility of same day discharge catheter ablation: initial German experience
Doctor S. Popescu (Luebeck, DE)
Abstract
Presentation thumbnail
Safety, obstetric and neonatal data trend of novel arrhythmia management in pregnant: zero-fluoroscopy catheter ablation vs. antiarrhythmic drugs
Doctor Z. Suleymen (Astana, KZ)
Abstract Slides Video
Presentation thumbnail
Sensor-enabled 3D electroanatomical model optimization in in-vivo porcine and benchtop models
Mr G. Wenzel (Minneapolis, US)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1: atrial tachyarrhythmias

The Event

Event poster

EHRA 2025

30 March 2025 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Real-world experience of atrial fibrillation ablation using a variable-loop circular catheter: a single-centre study
thumbnail
Congress Presentation
Role of 3D-electro-anatomical mapping on procedural characteristics and outcomes in pulsed-field ablation for atrial fibrillation
thumbnail
Congress Presentation
Ppulsed field ablation and ultra-high-density mapping for PVI: use of machine learning and data augmentation to guide procedure and identify recurrent tachycardia mechanisms at one-year follow-up

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources